SEER vs. GANX
Compare and contrast key facts about Seer, Inc. (SEER) and Gain Therapeutics, Inc. (GANX).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SEER or GANX.
Key characteristics
| SEER | GANX | |
|---|---|---|
| YTD Return | 19.07% | -43.49% |
| 1Y Return | 57.14% | -33.15% |
| 3Y Return (Ann) | -57.73% | -41.57% |
| Sharpe Ratio | 0.67 | -0.36 |
| Sortino Ratio | 1.41 | 0.09 |
| Omega Ratio | 1.16 | 1.01 |
| Calmar Ratio | 0.40 | -0.39 |
| Martin Ratio | 2.47 | -0.72 |
| Ulcer Index | 15.85% | 50.45% |
| Daily Std Dev | 58.77% | 100.38% |
| Max Drawdown | -98.25% | -94.08% |
| Current Drawdown | -97.25% | -88.32% |
Fundamentals
| SEER | GANX | |
|---|---|---|
| Market Cap | $133.26M | $55.41M |
| EPS | -$1.30 | -$1.31 |
| Total Revenue (TTM) | $14.35M | $64.80K |
| Gross Profit (TTM) | $2.20M | $90.00 |
| EBITDA (TTM) | -$94.53M | -$16.90M |
Correlation
The correlation between SEER and GANX is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
SEER vs. GANX - Performance Comparison
In the year-to-date period, SEER achieves a 19.07% return, which is significantly higher than GANX's -43.49% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
SEER vs. GANX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Seer, Inc. (SEER) and Gain Therapeutics, Inc. (GANX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
SEER vs. GANX - Dividend Comparison
Neither SEER nor GANX has paid dividends to shareholders.
Drawdowns
SEER vs. GANX - Drawdown Comparison
The maximum SEER drawdown since its inception was -98.25%, roughly equal to the maximum GANX drawdown of -94.08%. Use the drawdown chart below to compare losses from any high point for SEER and GANX. For additional features, visit the drawdowns tool.
Volatility
SEER vs. GANX - Volatility Comparison
The current volatility for Seer, Inc. (SEER) is 16.39%, while Gain Therapeutics, Inc. (GANX) has a volatility of 31.63%. This indicates that SEER experiences smaller price fluctuations and is considered to be less risky than GANX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
SEER vs. GANX - Financials Comparison
This section allows you to compare key financial metrics between Seer, Inc. and Gain Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities